Post Profile






Single-arm trials improve early access to rare cancer drugs

(European Society for Medical Oncology) Single-arm trials (SATs) can provide invaluable opportunities to speed up cancer drug development and approval, in particular for drugs with dramatic activity and strong biological rationale in small populations with high unmet need
read more

share

Related Posts


Niraparib significantly improves outcome of ovarian cancer patients in landmark trial

Health : EurekAlert: Health

(European Society for Medical Oncology) The PARP inhibitor niraparib significantly improves the outcome of platinum-sensitive recurrent ovarian cancer, according to full data from the ENGOT-OV16/NOVA trial presented for the first ti...

More research urged to compare and validate genomic tests for patients with early breast cancer

Health : Medical News Today

The European Society for Medical Oncology (ESMO) has welcomed preliminary clinical trial results that suggest genomic testing could allow many patients with early breast cancer to safely avoid chemotherapy. The new trial results[1],...

New Study Finds FDA Approval Process For Cancer Drugs Faster Than The European Medicines Agency (EMA)

Health : Medical News Today

The US Food and Drug Administration (FDA) is often criticized as inefficient compared to its European counterpart, the European Medicines Agency (EMA), particularly in the field of oncology. However, a new study appearing in Health ...

Biothera To Present Research Results At European Society For Medical Oncology World Gastrointestinal Congress

Health : Medical News Today

Biothera has been accepted to present data from its Phase II clinical trial in stage IV KRAS-mutant colorectal cancer at the European Society for Medical Oncology (ESMO) 13th World Congress on Gastrointestinal Cancer June 22-25 in B...

High response rate in phase I/II paediatric brain cancer trial

Health : EurekAlert: Health

(European Society for Medical Oncology) A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported...

Comments


Copyright © 2016 Regator, LLC